Quadrant Capital Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.69M | Buy |
4,375
+1,675
| +62% | +$621K | 0.05% | 362 |
|
|
2026
Q1 | $790K | Sell |
2,700
-67
| -2% | -$22K | 0.02% | 672 |
|
|
2025
Q4 | $970K | Sell |
2,767
-10
| -0.4% | -$3.38K | 0.03% | 574 |
|
|
2025
Q3 | $897K | Buy |
2,777
+8
| +0.3% | +$2.49K | 0.03% | 563 |
|
|
2025
Q2 | $1.08M | Sell |
2,769
-948
| -26% | -$381K | 0.04% | 436 |
|
|
2025
Q1 | $1.62M | Buy |
3,717
+2,141
| +136% | +$859K | 0.06% | 245 |
|
|
2024
Q4 | $581K | Sell |
1,576
-714
| -31% | -$299K | 0.04% | 294 |
|
|
2024
Q3 | $1.19M | Sell |
2,290
-48
| -2% | -$25.6K | 0.08% | 170 |
|
|
2024
Q2 | $1.27M | Buy |
2,338
+189
| +9% | +$99.9K | 0.09% | 148 |
|
|
2024
Q1 | $1.11M | Sell |
2,149
-101
| -4% | -$50.2K | 0.09% | 169 |
|
|
2023
Q4 | $1.06M | Buy |
2,250
+215
| +11% | +$99.4K | 0.09% | 163 |
|
|
2023
Q3 | $886K | Buy |
2,035
+9
| +0.4% | +$4.08K | 0.09% | 162 |
|
|
2023
Q2 | $900K | Buy |
2,026
+99
| +5% | +$45.7K | 0.09% | 155 |
|
|
2023
Q1 | $886K | Sell |
1,927
-309
| -14% | -$147K | 0.09% | 159 |
|
|
2022
Q4 | $1.15M | Buy |
2,236
+174
| +8% | +$88.3K | 0.13% | 114 |
|
|
2022
Q3 | $937K | Sell |
2,062
-6
| -0.3% | -$2.87K | 0.12% | 113 |
|
|
2022
Q2 | $998K | Buy |
2,068
+45
| +2% | +$22.3K | 0.13% | 110 |
|
|
2022
Q1 | $993K | Buy |
2,023
+164
| +9% | +$75K | 0.12% | 129 |
|
|
2021
Q4 | $862K | Sell |
1,859
-366
| -16% | -$154K | 0.1% | 145 |
|
|
2021
Q3 | $829K | Buy |
2,225
+384
| +21% | +$146K | 0.12% | 129 |
|
|
2021
Q2 | $703K | Buy |
1,841
+60
| +3% | +$22.9K | 0.1% | 147 |
|
|
2021
Q1 | $639K | Buy |
1,781
+153
| +9% | +$49.2K | 0.1% | 144 |
|
|
2020
Q4 | $523K | Buy |
1,628
+62
| +4% | +$19K | 0.1% | 144 |
|
|
2020
Q3 | $421K | Sell |
1,566
-56
| -3% | -$15.1K | 0.09% | 147 |
|
|
2020
Q2 | $427K | Sell |
1,622
-2,082
| -56% | -$555K | 0.09% | 150 |
|
|
2020
Q1 | $838K | Buy |
3,704
+1,731
| +88% | +$472K | 0.14% | 121 |
|
|
2019
Q4 | $572K | Buy |
1,973
+578
| +41% | +$159K | 0.07% | 255 |
|
|
2019
Q3 | $321K | Sell |
1,395
-653
| -32% | -$179K | 0.05% | 405 |
|
|
2019
Q2 | $563K | Sell |
2,048
-170
| -8% | -$46.4K | 0.09% | 196 |
|
|
2019
Q1 | $620K | Buy |
2,218
+726
| +49% | +$210K | 0.11% | 156 |
|
|
2018
Q4 | $376K | Buy |
1,492
+16
| +1% | +$4.4K | 0.1% | 168 |
|
|
2018
Q3 | $393K | Buy |
1,476
+36
| +3% | +$9.35K | 0.11% | 131 |
|
|
2018
Q2 | $326K | Sell |
1,440
-7
| -0.5% | -$1.62K | 0.11% | 141 |
|
|
2018
Q1 | $307K | Buy |
1,447
+7
| +0.5% | +$1.64K | 0.11% | 155 |
|
|
2017
Q4 | $307K | Buy |
1,440
+28
| +2% | +$5.96K | 0.12% | 145 |
|
|
2017
Q3 | $255K | Buy |
1,412
+13
| +0.9% | +$2.47K | 0.11% | 159 |
|
|
2017
Q2 | $221K | Sell |
1,399
-141
| -9% | -$25.3K | 0.1% | 171 |
|
|
2017
Q1 | $245K | Buy |
1,540
+74
| +5% | +$11.8K | 0.11% | 156 |
|
|
2016
Q4 | $202K | Buy |
1,466
+182
| +14% | +$24.4K | 0.1% | 143 |
|
|
2016
Q3 | $157K | Buy |
1,284
+92
| +8% | +$11.9K | 0.1% | 172 |
|
|
2016
Q2 | $149K | Sell |
1,192
-110
| -8% | -$15.1K | 0.1% | 169 |
|
|
2016
Q1 | $175K | Buy |
1,302
+108
| +9% | +$14.4K | 0.11% | 141 |
|
|
2015
Q4 | $162K | Buy |
1,194
+19
| +2% | +$2.62K | 0.11% | 160 |
|
|
2015
Q3 | $162K | Sell |
1,175
-28
| -2% | -$4.21K | 0.11% | 156 |
|
|
2015
Q2 | $193K | Buy |
+1,203
| New | +$192K | 0.12% | 141 |
|
Other funds holding ELV
Quadrant Capital Group's ELV Position: Q2 2026 in Review
Quadrant Capital Group increased its Elevance Health (ELV) stake by 62% in Q2 2026, buying an estimated $621K and bringing the position to 4,375 shares worth $1.69M. The position accounts for 0.05% of the portfolio, ranked #362.
Quadrant Capital Group first reported a position in ELV in Q2 2015 and has held it in 45 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Quadrant Capital Group held 4,375 shares of Elevance Health worth $1.69M as of Q2 2026.
- Quadrant Capital Group bought 1,675 Elevance Health shares in Q2 2026, an estimated $621K.
- Elevance Health made up 0.05% of Quadrant Capital Group's portfolio in Q2 2026, its #362 holding.
- Quadrant Capital Group first reported a position in Elevance Health in Q2 2015 and has held it in 45 quarters since.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.